{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:09:24Z","timestamp":1789718964706,"version":"4.0.1"},"reference-count":49,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7790","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T08:54:05Z","timestamp":1507884845000},"page":"9777-9785","source":"Crossref","is-referenced-by-count":12,"title":["MicroRNA-455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1"],"prefix":"10.3892","volume":"16","author":[{"given":"Lixia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"key20200713222854_b1-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200713222854_b2-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","article-title":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","volume":"133","author":"Mutch","year":"2014","journal-title":"Gynecol Oncol"},{"key":"key20200713222854_b3-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1746-1596-8-106","article-title":"Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer","volume":"8","author":"Nodin","year":"2013","journal-title":"Diagn Pathol"},{"key":"key20200713222854_b4-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"10816","DOI":"10.18632\/oncotarget.2522","article-title":"miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma","volume":"5","author":"Dong","year":"2014","journal-title":"Oncotarget"},{"key":"key20200713222854_b5-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/IGC.0b013e31822fa849","article-title":"The impact of peritoneal metastases in epithelial ovarian cancer with positive nodes","volume":"21","author":"Pereira","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"key20200713222854_b6-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/1078-0432.CCR-14-2497","article-title":"Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer","volume":"21","author":"Candido-dos-Reis","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200713222854_b7-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3892\/or.2016.5055","article-title":"MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene","volume":"36","author":"Bi","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200713222854_b8-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1016\/S0960-9822(02)00708-X","article-title":"MicroRNAs: Hidden in the genome","volume":"12","author":"Moss","year":"2002","journal-title":"Curr Biol"},{"key":"key20200713222854_b9-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1242\/dev.02073","article-title":"MicroRNA functions in animal development and human disease","volume":"132","author":"Alvarez-Garcia","year":"2005","journal-title":"Development"},{"key":"key20200713222854_b10-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"key20200713222854_b11-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1757-2215-5-44","article-title":"Current status and implications of microRNAs in ovarian cancer diagnosis and therapy","volume":"5","author":"Zaman","year":"2012","journal-title":"J Ovarian Res"},{"key":"key20200713222854_b12-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3892\/or.2016.5010","article-title":"MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200713222854_b13-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.2147\/OTT.S90976","article-title":"MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12","volume":"9","author":"Liang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20200713222854_b14-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-017-0615-x","article-title":"MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1\/c-JUN\/VEGFA pathway and predicts aggressive outcome in prostate cancer","volume":"16","author":"Lin","year":"2017","journal-title":"Mol Cancer"},{"key":"key20200713222854_b15-mmr-16-06-9777","first-page":"4762","article-title":"Low miR-498 expression levels are associated with poor prognosis in ovarian cancer","volume":"19","author":"Cong","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20200713222854_b16-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3892\/ijo.2017.3857","article-title":"MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells","volume":"50","author":"Zhou","year":"2017","journal-title":"Int J Oncol"},{"key":"key20200713222854_b17-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3892\/or.2017.5370","article-title":"MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2","volume":"37","author":"Li","year":"2017","journal-title":"Oncol Rep"},{"key":"key20200713222854_b18-mmr-16-06-9777","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.18632\/oncotarget.10339","article-title":"MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo","volume":"8","author":"Zeng","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713222854_b19-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1010428317691678","DOI":"10.1177\/1010428317691678","article-title":"MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion","volume":"39","author":"Guo","year":"2017","journal-title":"Tumour Biol"},{"key":"key20200713222854_b20-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20200713222854_b21-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.3892\/or.2016.5139","article-title":"MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2","volume":"36","author":"Qin","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200713222854_b22-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gene.2016.07.034","article-title":"miR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18","volume":"592","author":"Liu","year":"2016","journal-title":"Gene"},{"key":"key20200713222854_b23-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/cbin.10584","article-title":"MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1","volume":"40","author":"Li","year":"2016","journal-title":"Cell Biol Int"},{"key":"key20200713222854_b24-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713222854_b25-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2147\/OTT.S123324","article-title":"MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells","volume":"10","author":"Zhao","year":"2017","journal-title":"Onco Targets Ther"},{"key":"key20200713222854_b26-mmr-16-06-9777","doi-asserted-by":"publisher","DOI":"10.4238\/gmr16019479","article-title":"Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer","volume":"16","author":"Shen","year":"2017","journal-title":"Genet Mol Res"},{"key":"key20200713222854_b27-mmr-16-06-9777","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15028173","article-title":"MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer","volume":"15","author":"Zhuo","year":"2016","journal-title":"Genet Mol Res"},{"key":"key20200713222854_b28-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.1007\/s13277-016-5415-1","article-title":"MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway","volume":"37","author":"Xiaohong","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200713222854_b29-mmr-16-06-9777","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.3892\/ol.2016.4527","article-title":"miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2","volume":"11","author":"Zhao","year":"2016","journal-title":"Oncol Lett"},{"key":"key20200713222854_b30-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s13277-014-2766-3","article-title":"MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine\/threonine-protein kinase","volume":"36","author":"Chai","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713222854_b31-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.4752","article-title":"Up-regulation of miR-455-5p by the TGF-\u03b2-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B","volume":"240","author":"Cheng","year":"2016","journal-title":"J Pathol"},{"key":"key20200713222854_b32-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10735-013-9516-5","article-title":"Identification of miR-7 as an oncogene in renal cell carcinoma","volume":"44","author":"Yu","year":"2013","journal-title":"J Mol Histol"},{"key":"key20200713222854_b33-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/carcin\/bgp236","article-title":"Role of Notch signaling in colorectal cancer","volume":"30","author":"Qiao","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20200713222854_b34-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1158\/0008-5472.CAN-04-1890","article-title":"Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation","volume":"65","author":"Purow","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713222854_b35-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.2147\/OTT.S109606","article-title":"NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells","volume":"9","author":"Zhong","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20200713222854_b36-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-10-3196","article-title":"Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer","volume":"17","author":"Chu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20200713222854_b37-mmr-16-06-9777","first-page":"964","article-title":"Expression analysis of NOTCH1\/HES1\/PTEN signaling pathway in invasive bladder transitional cell carcinoma","volume":"92","author":"Sima","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20200713222854_b38-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/bjc.2014.135","article-title":"Notch1 activation is a poor prognostic factor in patients with gastric cancer","volume":"110","author":"Zhang","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200713222854_b39-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"e35022","DOI":"10.1371\/journal.pone.0035022","article-title":"High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma","volume":"7","author":"Ai","year":"2012","journal-title":"PLoS One"},{"key":"key20200713222854_b40-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000355674","article-title":"NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer","volume":"51","author":"Ogawa","year":"2013","journal-title":"Eur Surg Res"},{"key":"key20200713222854_b41-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1096\/fj.12-209247","article-title":"Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt\/TCF pathway","volume":"26","author":"Won","year":"2012","journal-title":"FASEB J"},{"key":"key20200713222854_b42-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1535-7163.MCT-11-0508","article-title":"A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells","volume":"11","author":"Sharma","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20200713222854_b43-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1535-7163.MCT-10-0677","article-title":"Notch signaling pathway as a therapeutic target in breast cancer","volume":"10","author":"Al-Hussaini","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20200713222854_b44-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s12032-009-9384-8","article-title":"Notch1 expression correlates with tumor differentiation status in ovarian carcinoma","volume":"27","author":"Wang","year":"2010","journal-title":"Med Oncol"},{"key":"key20200713222854_b45-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/IGC.0000000000000359","article-title":"Increased Notch1 expression is associated with poor overall survival in patients with ovarian cancer","volume":"25","author":"Alniaimi","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"key20200713222854_b46-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ygyno.2009.12.003","article-title":"Notch 1 signaling is active in ovarian cancer","volume":"117","author":"Rose","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20200713222854_b47-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4149\/neo_2016_506","article-title":"MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1","volume":"63","author":"Liang","year":"2016","journal-title":"Neoplasma"},{"key":"key20200713222854_b48-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ijo.2015.3257","article-title":"Theaflavin-3, 3\u2032-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways","volume":"48","author":"Gao","year":"2016","journal-title":"Int J Oncol"},{"key":"key20200713222854_b49-mmr-16-06-9777","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.3892\/or.2015.4320","article-title":"Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1\/Akt\/NF-\u03baB pathway","volume":"34","author":"Zou","year":"2015","journal-title":"Oncol Rep"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T21:33:10Z","timestamp":1594675990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,10,13]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7790"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7790","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]}}}